We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Advance Multi-Modality Imaging with PET

By HospiMedica staff writers
Posted on 09 Oct 2003
An agreement to address software fusion requirements as a complement to conventional hardware in a combined positron emission tomography/computed tomography (PET/CT) scanner has been announced by the University Hospital Essen (Germany). The hospital will use software developed by Mirada Solutions Limited (Oxford, UK; www.mirada-solutions.com). The agreement is part of Mirada's global program of clinical oncology research.

Mirada's fusion software offers various automated tools to combine medical images from different scanning modalities, such as magnetic resonance (MR), PET, single photon emission computed tomography (SPECT), and CT. The software can use different image data sets acquired at different times or data sets generated on imaging equipment from different manufacturers. Mirada is a developer of fusion software and analytical tools for medical imaging workstations.

University Hospital Essen is a leading academic and clinical center in combined PET/CT imaging. "Combined PET/CT imaging allows us to acquire jointly metabolic and anatomical information on patients as part of a single exam,” explained Thomas Beyer, Ph.D., who helped develop the concept of PET/CT in the USA. "While it addresses many challenges of multi-modality imaging, special viewing software is needed to fuse a series of PET/CT studies from the same patient over time.”




Related Links:
University Hospital Essen
Mirada Solutions
Mammography System (Analog)
MAM VENUS
Adjustable Mobile Barrier
M-458
High-Precision QA Tool
DEXA Phantom
Digital Radiographic System
OMNERA 300M

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.